The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 706 participants.
Also called NCT04612244
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 706 participants
- Sponsor
- Registry
-
NCT04612244
-
- Other papers using this trial's data
- Autonomic Effects of Pulsed Field vs Thermal Ablation for Treating Atrial Fibrillation: Subanalysis of ADVENT
- Comparison of cerebral safety after atrial fibrillation using pulsed field and thermal ablation: Results of the neurological assessment subgroup in the ADVENT trial
- Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
- Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04612244. Randomized; single masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2023-05-15 (actual). Results posted on 2024-11-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
- Acronym
- ADVENT
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- FARAPULSE Pulsed Field Ablation System
- Intervention (Device)
- RadioFrequency and Cryoballoon Ablation
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct04612244- Content hash
5e5681b420da9411ec07fa2603e88ef365738aca7e5349ed7058b6eb2295c298